chr1-11800250-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_005957.5(MTHFR):c.548G>A(p.Arg183Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000378 in 1,614,166 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_005957.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152180Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000596 AC: 15AN: 251492Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135920
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461868Hom.: 0 Cov.: 31 AF XY: 0.0000564 AC XY: 41AN XY: 727242
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152298Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74464
ClinVar
Submissions by phenotype
Homocystinuria due to methylene tetrahydrofolate reductase deficiency Pathogenic:4
A heterozygous missense variation in exon 3 of the MTHFR gene that results in the amino acid substitution of Glutamine for Arginine at codon 183 was detected. The observed variant c.548G>A (p.Arg183Gln) lies in the methylenetetrahydrofolate reductase domain of the MTHFR protein and has previously been reported in homozygous state, in patients affected with homocystinuria (Burda et al. 2015). Functional studies showed that the observed missense caused deleterious loss of MTHFR protein expression and activity (Burda et al. 2017). The variant has a minor allele frequency of 0.02% in the 1000 genomes and 0.006% in gnomAD database. The in silico predictions of the variant are probably damaging by PolyPhen-2 (HumDiv) and damaging by SIFT, LRT and MutationTaster2. The reference codon is conserved across species. In summary, the variant meets our criteria to be classified as pathogenic. -
- -
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 183 of the MTHFR protein (p.Arg183Gln). This variant is present in population databases (rs574132670, gnomAD 0.03%). This missense change has been observed in individual(s) with MTHFR deficiency (PMID: 25736335). ClinVar contains an entry for this variant (Variation ID: 187876). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MTHFR protein function. Experimental studies have shown that this missense change affects MTHFR function (PMID: 27743313). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
- -
not provided Pathogenic:2
MTHFR: PM2, PP1:Moderate, PM3:Supporting, PS3:Supporting -
Published functional studies demonstrate a damaging effect (residual enzyme activity in fibroblasts ranging from 20-22%) (Burda et al., 2015); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31589614, 26872964, 25736335, 27743313) -
Thrombophilia due to thrombin defect Pathogenic:1
The observed missense c.548G>A (p.Arg183Gln) variant in MTHFR gene has been reported in heterozygous/ homozygous states in multiple individuals affected with MTHFR-related disorders (Burda et al., 2015; Capalbo et al., 2019; Froese et al., 2016). Functional studies showed that the variant caused deleterious loss of MTHFR protein expression and activity (Burda et al., 2017). This variant is present with allele frequency of 0.006% in gnomAD Exomes. This variant has been reported to the ClinVar database as Likely Pathogenic/ Pathogenic. Multiple lines of computational evidence (Polyphen - Probably Damaging, SIFT - Damaging and MutationTaster - Disease causing) predict a damaging effect on protein structure and function for this variant. The reference amino acid of p.Arg183Gln in MTHFR is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Arg at position 183 is changed to a Gln changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as Pathogenic. -
Neural tube defects, folate-sensitive Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at